Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
14 /100
LOW RISK
Score updated Oct 13, 2026

TARS — Tarsus Pharmaceuticals, Inc. Dilution Risk Tracker

Track TARS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TARS — Get alerts when the score changes →

As of October 13, 2026, Tarsus Pharmaceuticals, Inc. (TARS) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. Tarsus Pharmaceuticals, Inc. has a market capitalization of $3.28B, 43.88M shares outstanding, 256 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TARS.
🔔 Track TARS — Get forecast alerts →

Market Data

Market Cap$3.28B
Shares Outstanding43.88M
Float32.12M
Cash$449.69M
Debt$72.76M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore14/100DilutionWatch score record
Shares Outstanding43.88MVerified float table or market cache
Public Float32.12MVerified float table or market cache
Market Cap$3.28BMarket data cache
Cash Runway51.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, 8-K 2, SC 13G/A 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 21.0% shares (2026Q1 vs prior)
256 institutional holders · 55.06M shares
#1 MORGAN STANLEY 5.90M shares
#2 JANUS HENDERSON GROUP PLC 4.48M shares
#3 Deep Track Capital, LP 3.60M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.07M
Days to Cover8.3
% of Float18.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2022-03-14
4 INSIDER TRANSACTION 2026-09-03
4 INSIDER TRANSACTION 2026-09-03
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TARS Dilution Snapshot

Tarsus Pharmaceuticals, Inc. (TARS) has a DilutionScore of 14/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TARS's DilutionScore has held steady at 14/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202614/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TARS shares outstanding have increased 1.1% from 42.56M (Mar 2026) to 43.02M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 202643.02M32.12M▼ 1.85%
May 10, 202643.02M32.72M▲ 1.45%
Mar 27, 202642.56M32.26M▲ 0.03%
Mar 23, 202642.56M32.25M▲ 0.12%
Mar 21, 202642.56M32.21M▼ 0.37%
Mar 09, 202642.56M32.33M▲ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TARS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TARS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TARS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TARS
TARS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.